Reimagine Flow Cytometry | Gloria Martrus, PhD
Tired of designing and validating your flow cytometry panels?
Want to optimize your time and get the most out of your precious samples?
Meet our new range of ready-to-use 45+ marker panels for in-depth profiling of T, B, NK and myeloid cells starting from only 300 μl of whole blood or 3 x 106 of PBMC.
This webinar showcased these new panels and how they expand your options to get best-in-class immune profiling.
CyTOF Summit on demand - Igniting Insight into Immuno-Oncology | 14 Jun 2022
Cutting Edge Cytometry and Clinical Trials: A Case Study | Caroline Roe, MLI
Method validation studies using the Maxpar® Direct™ Immune Profiling Assay™ | Sasidhar Vemula, PhD
Efficient, High-Content Immune Profiling with CyTOF® XT and MDIPA | Vinicius Motta, PhD
Single-Cell Immune Profiling Can Help Resolve Tumor Microenvironment Complexities
Mass Cytometry Barcoding Options for Live and Fixed Cells
Introducing CyTOF® XT and Maxpar™ Direct™ Assays for efficient high-content immune profiling
Mass Cytometry for Precision Medicine | Petter Brodin, MD, PhD
Leveraging CyTOF to track cancer vaccine induced T cell responses for up to 20 years | Erika Crosby
Profiling three layers of human immunity with CyTOF®, Olink® and automated RNA-seq
CyTOF in the Cancer Immune Monitoring and Analysis Centers (CIMAC) | Holden Maecker, PhD